Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis

Författare

  • Stefan Höglund
  • Jin Su
  • Sara Sandin-Reneby
  • Ákos Végvári
  • Stellan Hjertén
  • Ida-Maria Sintorn
  • Hillary Foster
  • Yi-Pyng Wu
  • Ingela Nyström
  • Anders Vahlne

Summary, in English

Capsid assembly during virus replication is a potential target for antiviral therapy. The Gag polyprotein is

the main structural component of retroviral particles, and in human immunodeficiency virus type 1 (HIV-1),

it contains the sequences for the matrix, capsid, nucleocapsid, and several small polypeptides. Here, we report

that at a concentration of 100 M, 7 of 83 tripeptide amides from the carboxyl-terminal sequence of the HIV-1

capsid protein p24 suppressed HIV-1 replication (>80%). The three most potent tripeptides, glycyl-prolylglycine-amide (GPG-NH2), alanyl-leucyl-glycine-amide (ALG-NH2), and arginyl-glutaminyl-glycine-amide (RQG-NH2), were found to interact with p24. With electron microscopy, disarranged core structures of HIV-1 progeny were extensively observed when the cells were treated with GPG-NH2 and ALG-NH2. Furthermore, nodular structures of approximately the same size as the broad end of HIV-1 conical capsids were observed at the plasma membranes of treated cells only, possibly indicating an arrest of the budding process. Corresponding tripeptides with nonamidated carboxyl termini were not biologically active and did not interact with p24.

Publiceringsår

2002

Språk

Engelska

Sidor

3597-3605

Publikation/Tidskrift/Serie

Antimicrobial Agents and Chemotherapy

Volym

46

Issue

11

Dokumenttyp

Artikel i tidskrift

Förlag

American Society for Microbiology

Ämne

  • Medical Engineering

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1098-6596